Tag: Diabetes: Type II

Risk ratios were 1.27 and 1.55 for GERD and its complications during a median follow-up of three years for GLP-1 RA versus SGLT-2 inhibitor users

Increased muscle echo intensity effectively identifies insulin resistance and impaired insulin sensitivity

Among adult patients with type 2 diabetes, CGM prescriptions less likely for those with non-English language preference

Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40

Greater weight loss and more diabetes remission seen among adult women with overweight, obesity and T2D

Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide

Most blood pressure benefits seen in the first three weeks of the diet

Greater reduction in urinary albumin-to-creatinine ratio seen for combination versus either agent alone

Higher all-cause and cardiovascular mortality predicted with concurrent hypertension and type 2 diabetes